Inventor · disambiguated record
Michael Klichinsky
Also filed as: KLICHINSKY MICHAEL
11 granted patents·9 pending applications·13 citations·filing 2016–2024
86Inventor score
Top patents by PatentIndex Score
20 records- 0196US11034749B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2016·Granted Jun 15, 2021·10 cites·28 claims
- 0286US11306133B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2020·Granted Apr 19, 2022·1 cites·13 claims
- 0385US2023279074A1Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses ThereofUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0484US11312939B2Constructs for chimeric antigen receptorsCARISMA THERAPEUTICS INC·Filed 2021·Granted Apr 26, 2022·2 cites·25 claims
- 0582US11498954B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2022·Granted Nov 15, 2022·0 cites·24 claims
- 0681US11407805B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted Aug 9, 2022·0 cites·30 claims
- 0781US11359002B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted Jun 14, 2022·0 cites·17 claims
- 0881US11332511B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted May 17, 2022·0 cites·30 claims
- 0981US11325963B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted May 10, 2022·0 cites·27 claims
- 1081US11319358B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted May 3, 2022·0 cites·24 claims
- 1181US11306134B2Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereofUNIV PENNSYLVANIA·Filed 2021·Granted Apr 19, 2022·0 cites·27 claims
- 1276US2025154530A1Modified monocytes/macrophages/dendritic cells expressing chimeric antigen receptors and uses in diseases and disorders associated with protein aggregatesUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 1363US2025382350A1Switch receptors and modified immune cellsCARISMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1461US11739297B2Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptorCARISMA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·0 cites·10 claims
- 1561US2021046110A1Modified monocytes/macrophages/dendritic cells expressing chimeric antigen receptors and uses in diseases and disorders associated with protein aggregatesUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 1653US2022119476A1Activation of Antigen Presenting Cells and Methods for Using the SameUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 1752US2023321144A1Modified immune cells for fibrosis and inflammationCARISMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1851US2024299543A1Self-polarizing immune cellsCARISMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1951US2023235286A1Mrna transfection of immune cellsCARISMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2042US2019161542A1Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage moleculeNOVARTIS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Klichinsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →